Short-Term Effects of Potassium Chloride Supplementation on Fibroblast Growth Factor 23 and Phosphate in Chronic Kidney Disease
Clin J Am Soc Nephrol
.
2022 Nov 10;CJN.09340822.
doi: 10.2215/CJN.09340822.
Online ahead of print.
Authors
Stanley Yeung
1
,
Martin Gritter
2
,
Rosa Wouda
3
,
Stephan Bakker
4
,
Jelmer van Zanden
5
,
Joris Rotmans
6
,
Ewout Hoorn
7
,
Liffert Vogt
8
,
Martin de Borst
9
Affiliations
1
S Yeung, Department of Internal Medicine, Division of Nephrology, University Medical Centre Groningen, Groningen, Netherlands m.h.yeung@umcg.nl.
2
M Gritter, Department of Internal Medicine, Division of Nephrology & Transplantation, Erasmus Medical Center, Rotterdam, Netherlands.
3
R Wouda, Department of Internal Medicine, Section of Nephrology, Amsterdam Cardiovascular Sciences, Amsterdam, Netherlands.
4
S Bakker, Department of Internal Medicine, Division of Nephrology, University Medical Centre Groningen, Groningen, Netherlands.
5
J van Zanden, Certe, Division of Clinical Chemistry, Martini Hospital, Groningen, Netherlands.
6
J Rotmans, Department of Internal Medicine, Leiden University Medical Center, Leiden, Netherlands.
7
E Hoorn, Department of Internal Medicine, Division of Nephrology & Transplantation, Erasmus Medical Center, Rotterdam, Netherlands.
8
L Vogt, Department of Internal Medicine, Section of Nephrology, Amsterdam Cardiovascular Sciences, Amsterdam, Netherlands.
9
M de Borst, Department of Internal Medicine, Division of Nephrology, University Medical Centre Groningen, Groningen, Netherlands.
PMID:
36357127
DOI:
10.2215/CJN.09340822
No abstract available